Aptevo Therapeutics Inc. - Common Stock (NQ:APVO)

1.760 UNCHANGED

Delayed Quote Updated: 3:58 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aptevo Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML

September 16, 2025

Via ACCESS Newswire

Foremost Clean Energy and Aptevo Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

September 05, 2025

Via ACCESS Newswire

Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules

September 04, 2025

Via ACCESS Newswire

Aptevo Highlights APVO442, a CD3-Directed Preclinical Candidate for Prostate Cancer

August 13, 2025

Via ACCESS Newswire

Aptevo Reports 85% Remission in Q2 ↗

August 11, 2025

Via The Motley Fool

Aptevo Therapeutics Reports 2Q25 Financial Results And Provides A Business Update

August 11, 2025

Via ACCESS Newswire

Aptevo Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

August 08, 2025

Via ACCESS Newswire

Benzinga Bulls And Bears: Circle, Sunrun, JetBlue — And Mideast Has Markets Nervous ↗

June 21, 2025

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 20, 2025

Via Benzinga

These stocks are moving in today's session ↗

June 20, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Aptevo Therapeutics Announces Closing of $8 Million Offering Priced At-the-Market Under Nasdaq Rules

June 20, 2025

Via ACCESS Newswire

Gapping stocks in Friday's session ↗

June 20, 2025

The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

Aptevo Expands Differentiated CD3 Portfolio with APVO455, Advancing a Suite of Targeted T-cell Engagers

June 20, 2025

Via ACCESS Newswire

Stay updated with the stocks that are on the move in today's pre-market session. ↗

June 20, 2025

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 20, 2025

Via Benzinga

Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

June 20, 2025

Via Benzinga

Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket ↗

June 20, 2025

Via Benzinga

Top movers in Thursday's after hours session ↗

June 19, 2025

Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

Which stocks are experiencing notable movement on Wednesday? ↗

June 18, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Crude Oil Moves Higher; US Weekly Jobless Claims Decline ↗

June 18, 2025

Via Benzinga

Discover the most active stocks in Wednesday's session. ↗

June 18, 2025

Curious about the most active stocks on Wednesday? Find out which stocks are dominating the market action!

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 18, 2025

Via Benzinga

Dow Surges 150 Points; Korn Ferry Earnings Top Views ↗

June 18, 2025

Via Benzinga

Topics Stocks

Here are the top movers in Wednesday's session. ↗

June 18, 2025

Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Aptevo Therapeutics Touts Data From Investigational Drug Trial For Aggressive Blood Cancer ↗

June 18, 2025

Aptevo stock spikes as new AML trial data show 85% remission rate with mipletamig triplet therapy, supported by strong safety and no CRS observed.

Via Benzinga

Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules

June 18, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 18, 2025

Via Benzinga

Mipletamig Demonstrates Compelling Clinical Activity in Frontline AML

June 18, 2025

Via ACCESS Newswire

Aptevo Participating in the BIO International Convention

June 13, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 22, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.